WHO Vaccine Evidence Compendium

🌍 Introducing the WHO Vaccine Evidence Compendium

A new one-stop resource to support countries in collecting and accessing reliable evidence for faster, evidence-based decisions on vaccine introduction, prioritization and portfolio optimization.

🔎 What is it?

The WHO Vaccine Evidence Compendium is a centralized, curated platform hosted on the NITAG Resource Centre, designed to streamline access to reliable and up to date immunization evidence for national decision-makers.

🎯 Objectives

• Enhance countries’ ability to make strategic, data-informed decisions on vaccine introduction, prioritization and optimization by improving access to reliable, up-to-date evidence

• Alleviate the workload of evidence gathering for NITAGs and EPI managers

📦 What does it include?

• Evidence packages for 4 pilot vaccines: Hexavalent, HPV, RSV, and PCV
• Standardized indicators and curated data aligned with existing tools ( including Evidence to Recommendation, New Vaccine Introduction Prioritization and Sequencing tool).
• Exportable content for use in workshops, presentations, and policy briefs, including tables comparing vaccine products.

🔮 What’s coming next?

• Ongoing updates aligned with SAGE reviews and country feedback.
• Expansion to additional vaccines in 2026.

🤝 Country driven, co-created with countries     

• Developed through consultations with NITAGs, regional workshops, and global partners to ensure relevance for country users  

• Guided by a Steering Committee of immunization experts to ensure quality, consistency and long-term utility

📣 How to access and share

• Available at : www.nitag-resource.org/compendium                                                        
• Share with NITAGs, WHO/UNICEF country offices, EPI managers, and partners.